Oliver Weigert

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Alessandro Pastore, Vindi Jurinović, Robert Kridel et al. · The Lancet Oncology · 2015 · 613 citations

Medicine, Immunology, Oncology +17

CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma

Kai Rejeski, Ariel Perez Perez, Pierre Sesques et al. · Blood · 2021 · 441 citations · Full text

Life Sciences, Hematology, Immunology +16

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Oreofe O. Odejide, Oliver Weigert, Andrew A. Lane et al. · Blood · 2013 · 429 citations · Full text

Medicine, Hematology, Oncology +11

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals

Nora Philipp, Maryam Kazerani, Alyssa Nicholls et al. · Blood · 2022 · 245 citations · Full text

Life Sciences, Immunology, Oncology +17

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

Vindi Jurinović, Robert Kridel, Annette M. Staiger et al. · Blood · 2016 · 229 citations · Full text

Medicine, Immunology, Oncology +14